PCC nomination supporting studies
IND-enabling studies
NDA/BLA-enabling studies
Exploration of the MOA
PD Evaluation (in vitro/in vivo)
ADME studies of chemical drugs
PK studies of biologics
Clinical development strategy
Phase I/II studies
Study design and operations
Medical monitoring
Pharmacovigilance
Data management
Phase II/III studies
Reporting and regulatory submission
Supporting clinical services
Safety Assessment
Efficacy Studies
DMPK Studies
POC Clinical Trials
Pivotal Clinical Trials
TriApex Profile
Social Responsibility
Join Us
Tel：+86 (025) 5819-6588 | + 86 189-5206-5101 | + 86 189-5206-5085 (Business Cooperation)
Email：bd@tri-apex.com | marketing@tri-apex.com
Address：No. 9 Xinglong Road, Jiangbei New Area, Nanjing, China
Official WeChat account
苏公网安备32011202001081 
Regulatory Policies
Project Management
Global
